Month: February 2017

NCPA Advocacy Center Update – Week Ending February 25, 2017

NCPA Hosts DIR Stakeholder Call:  This week NCPA hosted a call with industry partners providing an update on recent developments regarding NCPA’s efforts on pharmacy DIR fees.  Highlights of the briefing: Overview of recent Centers for Medicare & Medicaid Services

NCPA Advocacy Center Update – Week Ending February 18, 2017

House/Senate DIR Bills Introduced: This week, Reps. Morgan Griffith (R-Va.) and Peter Welch (D-Vt.), along with 16 of their colleagues, introduced H.R. 1038, the “Improving Transparency and Accuracy in Medicare Part D Drug Spending Act,” that would prohibit retroactive pharmacy

NCPA Advocacy Center Update – Week Ending February 11, 2017

NCPA Responds to PBM Efforts to Limit Potential Reforms:  An apparently leaked memorandum has surfaced from Mark Merritt, president and CEO of the Pharmaceutical Care Management Association (PCMA), to the association’s board of directors. It outlines PCMA’s strategies to mitigate

Top